Practical points that gastrointestinal fellows should know in management of COVID-19


ŞAHİN T., ŞİMŞEK C., BALABAN H. Y.

WORLD JOURNAL OF CLINICAL CASES, vol.10, no.16, pp.5133-5145, 2022 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 10 Issue: 16
  • Publication Date: 2022
  • Doi Number: 10.12998/wjcc.v10.i16.5133
  • Journal Name: WORLD JOURNAL OF CLINICAL CASES
  • Journal Indexes: Science Citation Index Expanded, Scopus, EMBASE
  • Page Numbers: pp.5133-5145
  • Keywords: COVID-19, Gastrointestinal diseases, Practical points, Endoscopy, Gastrointestinal fellows, PROTON PUMP INHIBITORS, SARS-COV-2 INFECTION, ACUTE-PANCREATITIS, MULTICENTER, EFFICACY, OUTCOMES, SAFETY, RISK

Abstract

Pandemics obligate providers to transform their clinical practice. An extensive effort has been put to find out feasible approaches for gastrointestinal diseases and also to manage coronavirus disease 2019 (COVID-19) related gastrointestinal conditions. Diarrhea, hepatitis, and pancreatitis can be seen in the COVID-19 course. Endoscopic procedures increase the risk of contamination for medical staff and patients despite precautions, therefore indications should be tailored to balance risks vs benefits. Furthermore, whether the immunosupression in inflammatory bowel diseases, liver transplantation, and autoimmune liver diseases increases COVID-19 related risks and how to modify immunosupression are topics of ongoing debate. This review aims to provide most up to date practical approaches that a gastrointestinal fellow should be aware on the problems and management of gastrointestinal and hepatobiliary diseases during the COVID-19 pandemic.